Ignite Planners, LLC Dexcom Inc Transaction History

Ignite Planners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$86.06 - $137.93 $51,377 - $82,344	-597 Reduced 4.76%	11,934 $1.11 Million
Q2 2023 Jul 11, 2023	SELL	$112.47 - $130.98 $5,061 - $5,894	-45 Reduced 0.36%	12,531 $1.61 Million
Q1 2023 Apr 17, 2023	SELL	$104.0 - $122.92 $49,504 - $58,509	-476 Reduced 3.65%	12,576 $1.46 Million
Q4 2022 Feb 02, 2023	BUY	$84.98 - $122.67 $13,936 - $20,117	164 Added 1.27%	13,052 $1.48 Million
Q2 2022 Jul 15, 2022	BUY	$67.99 - $132.89 $646,312 - $1.26 Million	9,506 Added 281.08%	12,888 $1.06 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $1,505 - $2,083	-16 Reduced 0.47%	3,382 $1.49 Million
Q4 2021 Feb 02, 2022	BUY	$129.87 - $162.82 $441,298 - $553,262	3,398 New	3,398 $1.47 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Ignite Planners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ignite Planners, LLC with notifications on news.